Abstract:The increasing use of illicit drugs has become a major global concern. Illicit drugs interact with the brain and the body altering an individual's mood and behavior. As the substance-of-abuse (SOA) crisis continues to spread across the world, in order to reduce trafficking and unlawful activity, it is important to use point-of-care devices like biosensors. Currently, there are certain conventional detection methods, which include gas chromatography (GC), mass spectrometry (MS), surface ionization, surface-enhanced Raman spectroscopy (SERS), surface plasmon resonance (SPR), electrochemiluminescence (ECL), high-performance liquid chromatography (HPLC), etc., for the detection of abused drugs. These methods have the advantage of high accuracy and sensitivity but are generally laborious, expensive, and require trained operators, along with high sample requirements, and they are not suitable for on-site drug detection scenarios. As a result, there is an urgent need for point-of-care technologies for a variety of drugs that can replace conventional techniques, such as a biosensor, specifically an immunosensor. An immunosensor is an analytical device that integrates an antibody-based recognition element with a transducer to detect specific molecules (antigens). In an immunosensor, the highly selective antigen–antibody interaction is used to identify and quantify the target analyte. The binding event between the antibody and antigen is converted by the transducer into a measurable signal, such as electrical, optical, or electrochemical, which corresponds to the presence and concentration of the analyte in the sample. This paper provides a comprehensive overview of various illicit drugs, the conventional methods employed for their detection, and the advantages of immunosensors over conventional techniques. It highlights the critical need for on-site detection and explores emerging point-of-care testing methods. The paper also outlines future research goals in this field, emphasizing the potential of advanced technologies to enhance the accuracy, efficiency, and convenience of drug detection.

Immunosensors—The Future of Pathogen Real-Time Detection

Recent Advances in Rapid Pathogen Detection Method Based on Biosensors

Electrochemical biosensors for pathogenic microorganisms detection based on recognition elements

Recent advances in immunoassays and biosensors for mycotoxins detection in feedstuffs and foods

Novel Biorecognition Elements against Pathogens in the Design of State-of-the-Art Diagnostics

Immunosensors for Detection of Pesticide Residues

Emerging Biomimetic Sensor Technologies for the Detection of Pathogenic Bacteria: A Commercial Viability Study

Meeting Current Public Health Needs: Optical Biosensors for Pathogen Detection and Analysis

From Small Molecules Toward Whole Cells Detection: Application of Electrochemical Aptasensors in Modern Medical Diagnostics

Application of selected biosensor techniques in clinical diagnostics

Application of nanotechnology in biosensors for enhancing pathogen detection.

Glycoprotein- and Lectin-Based Approaches for Detection of Pathogens

Recent Advancements in Receptor Layer Engineering for Applications in SPR-Based Immunodiagnostics

Recent advances in electrochemical aptasensors and genosensors for the detection of pathogens

Electroanalytical biosensors and their potential for food pathogen and toxin detection

The Evolution of Illicit-Drug Detection: From Conventional Approaches to Cutting-Edge Immunosensors—A Comprehensive Review

Current Trends in Mycotoxin Detection with Various Types of Biosensors

Recent advances in microfluidic-based spectroscopic approaches for pathogen detection

CRISPR-Cas- and Aptamer-based Systems for Diagnosing Pathogens: A Review

Biosensors for the Detection of Food Pathogens

Immunosensors in food, health, environment, and agriculture: a review